Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2023 | Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL-HBV and REVEAL-HCV cohort studies | Petrick, JL; Florio, AA; Zen, J; Wang, Y; Gewirtz, AT; Pfeiffer, RM; Loftus, S; Inglefield, J; Koshiol, J; Yang, B; Yu, K; Hildesheim, A; Chen, CJ ; Yang, HI ; Lee, MH; McGlynn, KA | INTERNATIONAL JOURNAL OF CANCER 153(1), 44-53 | |||
2021 | Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals | Koshiol, J; Argirion, I; Liu, Z; Kim, Lam, T; O'Brien, TR; Yu, K; McGlynn, KA; Petrick, JL; Pinto, L; Chen, CJ ; Hildesheim, A; Pfeiffer, RM; Lee, MH; Yang, HI | Alimentary pharmacology & therapeutics 54(6), 833-842 | |||
2020 | Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies | Petrick, JL; Florio, AA; Koshiol, J; Pfeiffer, RM; Yang, B; Yu, K; Chen, CJ ; Yang, HI ; Lee, MH; McGlynn, KA | International journal of cancer 147(10), 2743-2753 |